Edition:
India

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

2,006JPY
19 Sep 2018
Change (% chg)

¥54 (+2.79%)
Prev Close
¥1,952
Open
¥1,986
Day's High
¥2,020
Day's Low
¥1,982
Volume
9,571,400
Avg. Vol
7,190,824
52-wk High
¥2,020
52-wk Low
¥1,380

Summary

Name Age Since Current Position

Yoshihiko Hatanaka

61 2018 Chairman of the Board, Chairman of the Board of Directors, Representative Director

Kenji Yasukawa

58 2018 President, Chief Executive Officer, Representative Director

Nobuaki Tanaka

2018 Senior Executive Officer, Chief Director of Sales

Akihiko Iwai

2018 Senior Executive Officer, Chief Director of Research

Atsushi Kamide

2018 Senior Executive Officer, Director of External Affairs

Masatoshi Kuroda

2017 Senior Executive Officer, Chief Director of Asia & Oceania Business

Mitsunori Matsuda

2017 Senior Executive Officer, Chief Director of Pharmaceutical Technology

Chikashi Takeda

2018 Senior Executive Officer

Tadashi Hara

2017 Executive Officer, Director of Sales Strategy in Main Sales Unit

Masaaki Hirano

Executive Officer, Director of Business Planning

Yasuhiro Kanzaki

2016 Executive Officer, Manager of Osaka Office in Main Sales Unit

Yukio Matsui

2018 Executive Officer

Eisuke Nozawa

Executive Officer, Director of Pharmaceutical Affairs

Naoki Okamura

2018 Executive Officer

Takuya Oshida

2016 Executive Officer, Chief Director of Medical Affairs

Kazuhiro Sako

Executive Officer, President of Subsidiary

Fumiaki Sakurai

2018 Executive Officer

Taiji Sawamoto

2017 Executive Officer, Director of Research Program Promotion in Main Research Unit

Hideki Shima

2017 Executive Officer, Director of Technology Planning in Main Pharmaceutical Technology Unit

Yoshitsugu Shitaka

Executive Officer, President of Subsidiary

Shigeki Tanaka

2018 Executive Officer, Chief Director of Development

Shiro Yamamoto

Executive Officer, Manager of Tokyo Office in Main Sales Unit

Toru Yoshimitsu

2017 Executive Officer, Director of Business Promotion

Tomokazu Fujisawa

60 2018 Director

Hiroko Sakai

57 2018 Director

Yoshiharu Aizawa

72 2015 Independent Director

Hitoshi Kanamori

64 2018 Independent Director

Hiroo Sasaki

62 2018 Independent Director

Mamoru Sekiyama

69 2017 Independent Director

Noriyuki Uematsu

58 2018 Independent Director

Keiko Yamagami

57 2017 Independent Director

Akira Kamimura

2018 Director of Accounting

Biographies

Name Description

Yoshihiko Hatanaka

Mr. Yoshihiko Hatanaka has been serving as Chairman of the Board, Chairman of the Board of Directors and Representative Director in Astellas Pharma Inc. since April 1, 2018. His previous titles include President, Director of Business Planning in Main Business Strategy Unit, Executive Officer and Senior Executive Officer in the Company. He previously served as President and Chief Executive Officer in two US-based subsidiaries. He used to work for Fujisawa Pharmaceutical Co., Ltd. He obtained his bachelor's degree in Economics from Hitotsubashi University in May 1980.

Kenji Yasukawa

Mr. Kenji Yasukawa has been serving as President, Chief Executive Officer and Representative Director in Astellas Pharma Inc. since April 1, 2018. He joined the Company in April 1986. His previous titles include Vice President, Executive Officer, Senior Executive Officer and Director of Product Strategy in the Company. He used to work for Yamanouchi Pharmaceutical Co., Ltd. and a subsidiary.

Nobuaki Tanaka

Akihiko Iwai

Atsushi Kamide

Masatoshi Kuroda

Mitsunori Matsuda

Chikashi Takeda

Mr. Chikashi Takeda has been serving as Senior Executive Officer in Astellas Pharma Inc. since 2018. His previous titles include Chief Financial Officer, Executive Officer, Director of Business Promotion and Director of Business Planning in the Company.

Tadashi Hara

Masaaki Hirano

Yasuhiro Kanzaki

Yukio Matsui

Eisuke Nozawa

Naoki Okamura

Takuya Oshida

Kazuhiro Sako

Fumiaki Sakurai

Taiji Sawamoto

Hideki Shima

Yoshitsugu Shitaka

Shigeki Tanaka

Shiro Yamamoto

Toru Yoshimitsu

Tomokazu Fujisawa

Mr. Tomokazu Fujisawa has been serving as Director in Astellas Pharma Inc. since June 15, 2018. He is also a member of Audit Committee of the Company. His previous titles include Leader of J-SOX Project and Director of Audit in the Company. He used to work for Fujisawa Pharmaceutical Co., Ltd.

Hiroko Sakai

Ms. Hiroko Sakai has been serving as Director in Astellas Pharma Inc. since June 15, 2018. She is also a member of Audit Committee of the Company. She previously served as Director of Pharmaceutical Audit in Main Reliability Assurance Unit in the Company. She used to work for Yamanouchi Pharmaceutical Co., Ltd.

Yoshiharu Aizawa

Mr. Yoshiharu Aizawa has been serving as Independent Director in Astellas Pharma Inc. since June 2015. He is also an Honorary Professor of Kitasato University. He used to work for Keio University.

Hitoshi Kanamori

Mr. Hitoshi Kanamori has been serving as Independent Director in Astellas Pharma Inc. since June 15, 2018. He is also a member of Audit Committee of the Company. He is also serving as Partner in SANNO LAW OFFICE. He used to work for Tokyo Bar Association and University of Tsukuba.

Hiroo Sasaki

Mr. Hiroo Sasaki has been serving as Independent Director in Astellas Pharma Inc. since June 15, 2018. He is also a member of Audit Committee of the Company. He is also a Professor of Waseda University. He used to work for Nagoya City University and Ministry of Finance, Japan.

Mamoru Sekiyama

Mr. Mamoru Sekiyama has been serving as Independent Director in Astellas Pharma Inc. since June 19, 2017. He is also working for Marubeni Corporation. He used to work for Marubeni Power Systems Corporation.

Noriyuki Uematsu

Mr. Noriyuki Uematsu has been serving as Independent Director in Astellas Pharma Inc. since June 15, 2018. He is also a member of Audit Committee of the Company. He is also serving as Independent Director in Kamakura Shinsho, Ltd., as well as President and Representative Director in SU Consultant Co., Ltd., and working for Uematsu Certified Public Accountants Office. He used to work for Dentsu Inc., ABeam Consulting Ltd. and Deloitte Touche Tohmatsu LLC.

Keiko Yamagami

Ms. Keiko Yamagami has been serving as Independent Director in Astellas Pharma Inc. since June 19, 2017. She is also working for Tokyo Seiwa Law Office. She used to work for Dai-Ichi Tokyo Bar Association and Ministry of Justice, Japan.

Akira Kamimura